Scholarlink

<p>Subcision is one of the most frequently used surgical options in improving acne scarring. Concentrated growth factors (CGF), with the potential to assist in the repair and regeneration of tissues, have been extended to the field of cosmetic plastic surgery. Here, we investigate the safety and efficacy of combining CGF (the latest generation of platelet concentrates) with subcision as a novel treatment method. Sixty patients with clinically diagnosed acne scars received either subcision combined with CGF (<i>n</i> = 24) or subcision monotherapy (<i>n</i> = 36). Clinical characteristics and treatment outcomes were documented through photographs, questionnaires, and medical records, with side effects recorded. Both groups showed significant scar improvements, but the combination therapy demonstrated superior outcomes in ECCA score reduction compared to subcision treatment alone. Patients in the combination therapy group reported higher satisfaction levels, and side effects were minimal, except for increased ecchymosis and pain levels which resolved within an acceptable recovery time range for the patients. This combination approach efficiently treats severe acne scars without significant safety risks.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Treatment of acne scars using subcision combined with concentrated growth factors versus subcision monotherapy: a retrospective cohort study

  • 期刊论文

  • 发表日期：

    2025年2月24日

查看全文
  • Jingjing Zhu,
  • Yuxin Zhang,
  • Wei Wang,
  • Heng Wang,
  • Yu Guo,
  • Tianyi Liu

摘要

Subcision is one of the most frequently used surgical options in improving acne scarring. Concentrated growth factors (CGF), with the potential to assist in the repair and regeneration of tissues, have been extended to the field of cosmetic plastic surgery. Here, we investigate the safety and efficacy of combining CGF (the latest generation of platelet concentrates) with subcision as a novel treatment method. Sixty patients with clinically diagnosed acne scars received either subcision combined with CGF (n = 24) or subcision monotherapy (n = 36). Clinical characteristics and treatment outcomes were documented through photographs, questionnaires, and medical records, with side effects recorded. Both groups showed significant scar improvements, but the combination therapy demonstrated superior outcomes in ECCA score reduction compared to subcision treatment alone. Patients in the combination therapy group reported higher satisfaction levels, and side effects were minimal, except for increased ecchymosis and pain levels which resolved within an acceptable recovery time range for the patients. This combination approach efficiently treats severe acne scars without significant safety risks.